Tenascin-C modulates tumor stroma and monocyte/macrophage recruitment but not tumor growth or metastasis in a mouse strain with spontaneous mammary cancer

Journal of Cell Science

Volumn 112, Issue 12, 1999, Pages 1855-1864

  Talts, Jan F ^a   Wirl, Gerhard ^b   Dictor, Michael ^c   Muller, William J ^d   Fässler, Reinhard ^c  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d NONE

Author keywords

Knockout; Mammary cancer; Metastasis; Mouse; Tenascin C; Tumor stroma

Indexed keywords

SCLEROPROTEIN; TENASCIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; LUNG METASTASIS; MACROPHAGE; MALE; MONOCYTE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; STROMA; TUMOR GROWTH; TUMOR VOLUME;

ANIMALS; CELL DIVISION; COCULTURE TECHNIQUES; FEMALE; LUNG NEOPLASMS; MACROPHAGES; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; MONOCYTES; STROMAL CELLS; TENASCIN;

ANIMALIA;

EID: 0032811083     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Aszodi, A., Chan, D., Hunziker, E., Bateman, J. F. and Fässler, R. (1998). Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. J. Cell. Biol. 143, 1399-1412.
2. Bourdon, M. A., Wikstrand, C. J., Furthmayer, H., Matthews, T. J. and Bigner, D. D. (1983). Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res. 43, 2796-2805.
3. Camps, J., Chang, S., Hsu, T., Freeman, M. R., Hong, S. J., Zhau, H. E., von Eschenbach, A. C. and Chung, L. W. (1990). Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc. Natl. Acad. Sci. USA 87, 75-79.
4. Canfield, A. E. and Schor, A. M. (1995). Evidence that tenascin and thrombospondin-1 modulate sprouting of epithelial cells. J. Cell Sci. 108, 797-809.
5. Chammas, R., Taverna, D., Cella, N., Santos, C. and Hynes, N. E. (1994). Laminin and tenascin assembly and expression regulate HC11 mouse mammary cell differentiation. J. Cell Sci. 107, 1031-1040.
6. Chiquet, M. and Fambrough, D. M. (1984). Chick myotendinous antigen II. A novel extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. J. Cell Biol. 98, 1937-1946.
7. Chiquet-Ehrismann, R., Mackie, E. J., Pearson, C. A., Beck, K. and Sakakura, T. (1986). Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47, 131-139.
8. Chung, C., Zardi, L. and Erickson, H. P. (1995). Binding of tenascin-C to soluble fibronectin and matrix fibrils. J. Biol. Chem. 270, 29012-29017.
9. Chung, L. (1991). Fibroblasts are critical determinants in prostatic cancer growth and dissemination. Cancer Metast. Rev. 10, 263-274.
10. Deryugina, E. I. and Bourdon, M. A. (1996). Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin. J. Cell Sci. 109, 643-652.
11. Ekblom, M., Fässler, R., Thomasini-Johansson, B., Nilsson, K. and Ekblom, P. (1993). Downregulation of tenascin expression by glucocorticoids in bone marrow stromal cells and fibroblasts. J. Cell Biol. 123, 1037-1045.
12. Erickson, H. P. and Bourdon, M. A. (1989). Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Ann. Rev. Cell Biol. 5, 71-92.
13. Erickson, H. P. and Inglesias, J. L. (1984). A six-armed oligomer isolated from cell surface fibroneclin preparations. Nature 311, 267-269.
14. Faissner, A., Scholze, A. and Götz, B. (1994). Tenascin glycoproteins in the developing neural tissues: only decoration? Persp. Dev. Neurobiol. 2, 53-66.
15. Fässler, R., Sasaki, T., Timpl, R., Chu, M. L. and Werner, S. (1996). Differential regulation of fibulin, tenascin-C, and nidogen expression during wound healing of normal and glucocorticoid-treated mice. Exp. Cell. Res. 222, 111-116.
16. Forsberg, E., Hirsch, E., Fröhlich, L., Meyer, M., Ekblom, P., Aszodi, A., Werner, S. and Fässler, A. (1996). Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proc. Natl. Acad. Sci. USA 93, 6594-6599.
17. Gerdes, J., Scholzen, T., Gerlach, C., Kubbutat, M. H. G. and Zentgraf, H. (1997). Assessment of cell proliferation in murine tissues with a polyclonal antiserum against the murine Ki-67 protein. Eur. Cell Biol. 72 (Suppl. 43), 88.
18. Götz, B., Scholze, A., Clement, A., Joester, A., Schütte, K., Wigger, F., Frank, R., Spiess, E., Ekblom, P. and Faissner, A. (1996). Tenascin-C contains distinct adhesive, anti-adhesive and neurite outgrowth promoting sites for neurons. J. Cell Biol. 132, 681-699.
19. Guy, C. T., Cardiff, R. D. and Muller, W. J. (1992). Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12, 954-961.
20. Hanahan, D., and Folkman, J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell86. 353-364.
21. Hume, D., Robinson, A., McPherson, G. and Gordon, S. (1983). The mononuclear phagocyte system of the mouse defined by immunohistochemical localisation of antigen. J. Exp. Med. 158, 1522-1536.
22. Inaguma, Y., Kusakabe, M., Mackie, E. J., Pearson, C. A., Chiquet-Ehrismann, R. and Sakakura, T. (1988). Epithelial induction of stromal tenascin in the mouse mammary gland: from embryogenesis to carcinogenesis. Dev. Biol. 128, 245-255.
23. Koukoulis, G. K., Gould, V. E., Bhattacharya, A., Gould, J. E., Howeedy, A. A. and Virtanen, I. (1991). Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications. Hum. Pathol. 22, 636-643.
24. Langenfeld-Oster, B., Faissner, A., Irintchev, A. and Wernig, A. (1994) Polyclonal antibodies against NCAM and tenascin delay endplate reinnervation. J. Neurocytol. 23, 591-604.
25. Liotta, L., Steeg, P. and Stetler-Stevenson, W. (1991). Cancer metastasis: an imbalance of positive and negative regulation. Cell 64, 327-336.
26. Mackie, E. J., Halfter, W. and Liverani, D. (1988). Induction of tenascin in healing wounds. J. Cell Biol. 107, 2757-2767.
27. Mackie, E. J. (1997). Molecules in focus: tenascin-C. Int. J. Biochem. Cell Biol. 29, 1133-1137.
28. Mann, K., Deutzmann, R. and Timpl, R. (1988). Characterization of proteolytic fragments of the laminin-nidogen complex and their activity in ligand binding assays. Eur. J. Biochem. 178, 71-80.
29. Matrisian, L. M. and Hogan, B. L. (1990). Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. Curr. Top. Dev. Biol. 24, 219-259.
30. Natali, P. G., Nicotra, M. R., Bigotti, A., Botti, C., Castellani, P., Risso, A. M. and Zardi, L. (1991). Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues. Int. J. Cancer 47, 811-816.
31. Ohta, M., Sakai, T., Saga, Y., Aizawa, S. and Saito, M. (1998). Suppression of hematopoietic activity in tenascin-C-deficient mice. Blood 91, 4074-4083.
32. Pan, T.-C., Sasaki, T., Zhang, R.-Z., Fässler, R., Timpl, R. and Chu, M.-L. (1993). Structure and expression of fibulin-2, a novel extracellular matrix protein with multiple EGF-like repeats and consensus motifs for calcium binding. J. Cell Biol. 123, 1269-1277.
33. Patthy, L. (1991). Exons - original building blocks of proteins? BioEssays 13, 187-192.
34. Phillips, G. R., Edelmann, G. M. and Crossin, K. L. (1995) Separate cell binding sites within cytotactin/tenascin differentially promote neurite outgrowth. Cell Adhes. Commun. 3, 257-271.
35. Reichmann, E., Ball, R., Groner, B. and Friis, R. R. (1989). New mammary epithelial and fibroblastic cell clones in coculture form structures competent to differentiate functionally. J. Cell Biol. 108, 1127-1138.
36. Ruegg, C. R., Chiquet-Ehrismann, R. and Alkan, S. S. (1989). Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proc. Natl. Acad. Sci. USA 86, 7437-7441.
37. Saga, Y., Tsukamoto, T., Jing, N., Kusakabe, M. and Sakakura, T. (1991). Murine tenascin: cDNA cloning, structure and temporal expression of isoforms. Gene 104, 177-185.
38. Saga, Y., Yagi, T., Ikawa, Y., Sakakura, T. and Aizawa, S. (1992). Mice develop normally without tenascin. Genes Dev. 6, 1821-1831.
39. Talts, J. F., Aufderheide, E., Sorokin, L., Ocklind, G., Matteon, R. and Ekblom, P. (1993). Induction of mouse tenascin expression by a human sarcomatoid Wilms' tumor cell line growing in nude mice. Int. J. Cancer 54, 868-874.
40. Talts, J. F., Weller, A., Timpl, R., Ekblom, M. and Ekblom, P. (1995). Regulation of mesenchymal extracellular matrix protein synthesis by transforming growth factor-β and glucocorticoids in tumor stroma. J. Cell Sci. 108, 2153-2162.
41. Talts, J. F., Eng, H., Zhang, H.-Y., Faissner, A. and Ekblom, P. (1997). Characterization of monoclonal antibodies against tenascin-C: no apparent effect on kidney development in vitro. Int. J. Dev. Biol. 41, 39-48.
42. Talts, J. F., Falk, M. and Ekblom, M. (1998). Expansion of the nonadherent myeloid cell population by monoclonal antibodies against tenascin-C in murine long-term bone marrow cultures. Exp. Hematol. 26, 552-561.
43. Treisman, R., Novak, U., Favaloro, J. and Kamen, R. (1981). Transformation of rat cells by an altered polyoma virus genome expressing only the middle T protein. Nature 292, 595-600.
44. van den Hoof, A. (1988). Stromal involvement in malignant growth. Adv. Cancer Res. 50, 159-196.
45. Weller, A., Beck, S. and Ekblom, P. (1991). Amino acid sequence of mouse tenascin and differential expression of two tenascin isoforms during embryogenesis. J. Cell Biol. 112, 355-362.
46. Wernert, N. (1997). The multiple roles of tumour stroma. Virchows Arch. 430, 433-43.
47. Wirl, G. and Pfäffle, M. (1988). Collagen-binding proteins of rat mammary tumor epithelial cells: a biochemical and immunological study. Exp. Cell Res. 176, 20-37.
48. Wirl, G., Hermann, M., Ekblom, P. and Fässler, R. (1995). Mammary epithelial cell differentiation in vitro is regulated by an interplay of EGF action and tenascin-C downregulation. J. Cell Sci. 108, 2445-2456.
49. Zagzag, D., Friedlander, D. R., Miller, D. C., Dosik, J., Cangiarella, J., Kostianovsky, M., Cohen, H., Grumet, M. and Greco, M. A. (1995). Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res. 55, 907-914.
50. Zagzag, D., Friedlander, D. R., Dosik, J., Chikramane, S., Chan, W., Greco, M. A., Allen, J. C., Dorovini-Zis, K. and Grumet, M. (1996). Tenascin-C expression by angiogenic vessels in human astrocytomas and by human endothelial cells in vitro. Cancer Res. 56, 182-189.